Antifilaggrin antibodies in recent-onset arthritis

Scandinavian Journal of Rheumatology

Volumn 28, Issue 2, 1999, Pages 113-116

  Aho, Kimmo ^a   Palosuo, Timo ^a   Lukka, Matti ^a   Kurki, Pekka ^b   Isomäki, Heikki ^c   Kautiainen, Hannu ^c   Von Essen, Robert ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL AGENCY FOR MEDICINES   (Finland)

^c RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^d NONE

Author keywords

Antifilaggrin antibody; Antikeratin antibody; Antiperinuclear factor; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

ANTIPERINUCLEAR FACTOR; AUTOANTIBODY; FILAGGRIN; FILAGGRIN ANTIBODY; KERATIN ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS;

EID: 0032964046     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097499442586     Document Type: Article

References (15)

1. 1. Masi AT, Feigenbaum SL. Seronegative rhematoid arthritis. Fact or fiction? Arch Intern Med 1983;143:2167-72.
2. 2. Isomäki HA. An epidemiologically based follow-up study of recent arthritis. Incidence, outcome and classification. Clin Rheumatol 1987;6 Suppl 2:53-9.
3. 3. Ménard H.-A, el Amine M, Després N. Rheumatoid arthritis associated autoimmune systems. J Rheumatol 1998;25:835-7.
4. 4. Aho K, Palosuo T, Kurki P. Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications. Semin Arthritis Rheum 1994;23:379-87.
5. 5. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 1992;51:743-6.
6. 6. Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, et al. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol 1996;35:620-4.
7. 7. Berthelot J.-M, Maugars Y, Castagné A, Audrain M, Prost A. Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled. Ann Rheum Dis 1997;56:123-5.
8. 8. Simon M, Girbal E, Sebbag M, Gomès-Daudrix V, Vincent C, Salama G, et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies", autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993;92:1387-93.
9. 9. Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux J.-J, et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672-9.
10. 10. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, et al. Purification of filaggrin from human epidermis and measurement of anti-filaggrin antibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115:294-302.
11. 11. Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux J.-J, Cantagrel A, et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol 1998;25:838-46.
12. 12. Slack SL, Mannik M, Dale BA. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol 1998;25:847-51.
13. 13. Schellekens GA, de Jong BAW, van den Hogen FHJ, van de Putte LBA, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101: 273-81.
14. 14. von Essen R, Kurki P, Isomäki H, Okubo S, Kautiainen H, Aho K. Prospects for an additional laboratory criterion for rheumatoid arthritis. Scand J Rheumatol 1993;22:267-72.
15. 15. Aho K, von Essen R, Kurki P, Palosuo T, Heliövaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993;20:1278-81.